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ABSTRACT
Although salt formation is the most ubiquitous and effective method of increasing
the solubility and dissolution rates of acidic and basic drugs, it consumes large quantities
of organic solvents and is a batch process. Herein, we show that the dissolution rate of
indomethacin (a poorly water-soluble drug) can be increased by using hot melt extrusion
of a 1:1 (mol/mol) indomethacin:tromethamine mixture to form a highly crystalline salt,
the physicochemical properties of which are investigated in detail. Specifically, pH–
solubility studies demonstrated that this salt exhibited a maximal solubility of 19.34
mg/mL (>1000 times that of pure indomethacin) at pH 8.19. A solvent evaporation
technique was also used for salt formation. Spectroscopic analyses (infrared, nuclear
magnetic resonance) of both methods; demonstrated, in situ salt formation with proton
transfer. Powder X-ray diffraction and differential scanning calorimetry confirmed the
crystalline nature of salts formed in both methods. Even though a number of amorphous
salts of acidic drugs have been reported, the formation of a crystalline salt of an acidic
drug by hot melt extrusion is completely unprecedented, which makes this study an
important benchmark for the pharmaceutical production industry.
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CHAPTER I

INTRODUCTION
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Molecular modeling and high-throughput screening have enabled the discovery of
numerous

pharmaceutically

active

small

molecules,

the

development

and

commercialization of which, however, are often hindered by poor solubility in aqueous
media, low bioavailability, and high toxicity [1]. Therefore, a number of techniques (e.g.,
amorphous solid dispersion, amorphous solid solution, salt formation, co-crystal
formation, surface modification, cyclodextrin complexation, and the use of selfemulsifying systems) have been developed to improve the dissolution and thus increase
the bioavailability of poorly water-soluble drugs [2].
Since many drugs are weak acids or weak bases thus they can easily form salts
with suitable counter ions, the biopharmaceutical properties of new drug candidates are
most commonly improved by salt formation [3,4]. More than 50% of marketed drugs are
available in salt form, making salt formation the preferred solubilization technique. In view
of the fact that salt formation is an acid-base reaction involving a neutralization reaction
or proton transfer from the acidic moiety to the basic group and usually requires low
activation energy, it is theoretically applicable to all compounds with acidic or basic
properties. The relative strength of the acid or base is particularly important, determining
whether or not salt formation occurs and being a measure of the stability of the resulting
salt [5]. In the pharmaceutical industry, salts are typically produced in solution by batch
processing, which leads to the consumption of large amounts of solvents [6]. Although
the above approach allows one to control the process rate and yield, the use of solvents
can harm the environment, jeopardize patient health, and incur additional costs due to
variability issues and batch processes will delay its commercialization [7]. Moreover, the
need to remove solvents at the end of the reaction results in the exposure of the salt to
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stimuli such as heat, which may cause other problems [8]. Therefore, salt formation is
often performed as a multistep process [9].
A cleaner, greener, and more productive approach corresponds to salt formation
facilitated by an input of mechanical and/or thermal energy. Although HME has been
extensively used in the plastics industry since the 1930s, research and development
within the pharmaceutical manufacturing industry over the past two decades has
propelled this technique as an alternative “platform technology” for solid dosage form
development. HME offers distinct advantages over traditional pharmaceutical formulation
techniques, i.e., it is a solvent-free technique, allows continuous operation and thus
requires fewer processing steps, does not require major downstream processing such as
compression, and is known to improve bioavailability [10,11]. Literature presents salt
formation, but in their amorphous forms [12,13], which are characterized by unpredictable
behavior due to their thermodynamic instability and increased molecular mobility.
Consequently, this unpredictability leads to elevated chemical degradation rates and the
occurrence of spontaneous recrystallization. Therefore, crystalline salt formation offers
the advantages of kinetic/thermodynamic stability and decreased susceptibility to
chemical degradation [14–16].
Herein, we report a solvent-free and continuous one-step HME-based process for
the formation of a crystalline salt of an acidic drug (indomethacin (Indo)), demonstrating
that the obtained product shows physicochemical properties similar to those of the
crystalline salt prepared by solvent evaporation (SE).
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Table 1 presents the critical attributes of the utilized drug and the co-former.
According to the biopharmaceutics classification system, Indo is a Class II drug with a
pKa of 4.5 and a melting point of 162 °C [17,18]. The bioavailability of Indo is rate-limited
by its solubility and dissolution rate [19], which has inspired extensive research aimed at
improving its dissolution behavior. In this study, tromethamine (Tro), a highly watersoluble amino sugar with a pKa of 8.07 and a melting point of 171 °C, was selected as the
salt-forming base in view of the fact that it is an FDA-approved excipient commonly used
as a salt former for oral and intravenous drug administration [20]. It is generally accepted
that salt formation occurs if the ΔpKa between the acid and the base is greater than three
[21,22]. Herein, based on the pKa difference between Indo and Tro (ΔpKa = 3.6), we
hypothesized that in situ proton transfer between these species could occur during melt
extrusion and thus effectively enhance the dissolution performance and physical stability
of Indo. The thermally induced in situ acid−base reaction between Indo and Tro was
investigated by differential scanning calorimetry (DSC) and hot-stage polarized light
microscopy (HSPLM). Additionally, Fourier transform infrared spectroscopy (FTIR) and
solution-phase

1H/13Cnuclear

magnetic

resonance

(NMR)

and

Distortionless

Enhancement by Polarization Transfer (DEPT 135) was applied to confirm the occurrence
of the above proton transfer. The morphology of as-prepared salts was investigated using
scanning electron microscopy (SEM), and the dissolution properties of salts prepared by
SE and HME under non-sink conditions at pH 7 were determined using simulated
intestinal fluid (enzyme free) as the dissolution medium. Finally, powder X-ray diffraction
(PXRD) and DSC were used to confirm the crystalline nature of the prepared salt.
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Molecules

Molecular
Weight

pKa

Solubility in
Water

Indomethacin

357.69 g/mol

4.5

0.9 µg/ml

Tromethamine

121.14 g/mol

8.07

550 mg/ml

Table 1 Physico-chemical Properties of Indo and Tro.
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Melting
Point
162 °C

171 °C

Category
Rheumatoid
Arthritis
FDA
Approved
Coformer

CHAPTER II

MATERIALS AND METHODS
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2.1 Materials
Indomethacin (C19H16ClNO4, ≥98% purity, MW = 357.69 g/mol, melting point = 162
°C, pKa = 4.5) was purchased from Combi-Blocks, Inc. (San Diego, California).
Tromethamine (C4H11NO3, ≥99% purity, MW = 121.14g/mol, melting point = 142 °C
(metastable polymorph) and 171 °C (stable polymorph), pKa = 8.07) was obtained from
AK Scientific, Inc. (Union City, California). All solvents and other chemicals were sourced
from Fisher Scientific (Waltham, Massachusetts) and were of analytical reagent grade.

2.2 Methods
2.2.1 Salt preparation by SE
The solubility of Indo and Tro in anhydrous 200 proof ethanol equal 6.5 mg/mL and
14.6 mg/mL, respectively. To prepare the Indo-Tro salt, the above constituents (1 mmol
each) were dissolved at room temperature in 200 proof ethyl alcohol (64 mL) in a 250-mL
beaker upon stirring, and the resulting solution was heated to 80 °C to ensure the
complete dissolution of all solids or nuclei. The above temperature was maintained until
ethanol evaporation–induced supersaturation was reached, and the solution was
subsequently cooled to room temperature [23]. The precipitated Indo-Tro salt was filtered,
dried, and stored in a desiccator for the duration of the study. Subsequently, the dried
product was characterized by HSPLM, PXRD, DSC, thermogravimetric analysis (TGA),
solution-phase 1H/13C NMR, DEPT 135 and attenuated total reflectance FTIR (ATR-FTIR)
spectroscopy.
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2.2.2 Salt preparation by HME
Indo and Tro were passed through a US#30 mesh screen to remove aggregates.
A 1:1 (mol/mol) physical mixture of Indo (35.8 g, 0.1 mol) and Tro (12.1 g, 0.1 mol) was
tumble-mixed at 25 rpm for 20 min using a Maxiblend™ blender (GlobePharma, New
Brunswick, NJ, USA). The blended mixture was fed into zone 1 of a 11-mm co-rotating
twin screw extruder (Process 11, Thermo Fisher Scientific, Waltham, Massachusetts)
using a single-screw volumetric feeder at a mass flow rate of 5% (~0.24 g/min), the
extruder screws rotated at a speed of 150 rpm and the zones were heated at 135 °C. The
extruder with a length-to-diameter ratio of 40:1 and eight electrically heated zones was
operated utilizing a die and a 3-mm die insert, and the product was collected at the exit
end of the extruder. To monitor the progress of salt formation, samples from zones 3, 5,
and 8 of the extruder were taken out at the end of each experiment and analyzed by DSC.

2.2.3 pH–solubility profile
Suspensions of Indo in 25 mL of water were prepared in 100-mL conical flasks at
25

°C

using

a

ThermoScientific

orbital

shaker

(ThermoScientific,

Waltham,

Massachusetts). The pH of as-obtained suspensions (5.04) was adjusted by dropwise
addition of aqueous Tro (0.1 and 0.5 M), and the pH change was monitored with a pH
meter. It was ensured that excess solid phase always remained in equilibrium with the
suspension. After each pH adjustment, suspensions were equilibrated by shaking for at
least 2 h, and withdrawn aliquots were filtered through a 0.22-μm centrifuge tube filter
(MilliporeSigma, Burlington, Massachusetts) and subjected to 5-min ultracentrifugation at
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10000 rpm and 25 °C. No significant change in drug solubility was observed when
equilibration was continued for up to 24 h. After appropriate dilutions, the filtered solutions
were assayed for Indo by reverse-phase high-performance liquid chromatography
(HPLC; Waters® e2696 Separations Module) using a Kinetex® 5-μm C18 (250 × 4.6 mm)
column, Waters® 2489 UV/visible detector at 254 nm, and 1:1 (v/v) acetonitrile/phosphate
buffer (pH 7.8) as the mobile phase. The above solvent mixture was also used for aliquot
dilution.

2.2.4 DSC analysis
DSC analysis was performed using a Model 25 differential scanning calorimeter
(TA Instruments, Newcastle, Delaware) equipped with a refrigerator cooling system 120.
Nitrogen was used as the purge gas at a flow rate of 50 mL/min. Indium metal was used
for instrument calibration. For sample analysis, 2−5 mg samples were accurately weighed
and sealed inside standard TA Tzero aluminum pans. For thermal characterization, pure
Indo and pure Tro were heated at 10 °C/min from 25 to 200 °C. To characterize the IndoTro interaction, their 1:1 (mol/mol) mixture was heated at 10 °C/min from 25 to 185 °C,
and the above thermal program was also used to characterize salts obtained by SE and
HME. All the results were analysed using Trios software (TA Instruments, Newcastle,
Delaware).
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2.2.5 HSPLM imaging
An Agilent Cary 620 IR optical microscope (Agilent, Santa Clara, CA, USA)
equipped with an electronically controlled hot stage (T95 LinkPad and FTIR 600, Linkam,
Tadworth, UK) was used, and the crystallinity of Indo and Tro were evaluated based on
the corresponding images captured under crossed polarizers. During imaging, samples
were heated to 200 °C at a ramp rate of 20 ± 0.1 °C/min, and the temperature was
maintained until visual analysis was complete.

2.2.6 PXRD analysis
PXRD patterns were recorded on a MiniFlex 600 diffractometer (Rigaku
Corporation, Tokyo, Japan) equipped with a Cu K radiation source (λ = 1.5406 Å).
Measurements were conducted at an acceleration voltage of 40 kV and a current of 15
mA. Scanning was performed over an angle range of 2θ = 5–35° at a step size of 0.02°
and a dwell time of 0.5 s. The results were analyzed using MDI Jade 8.5 software
(Materials Data, Inc., Livermore, CA).

2.2.7 SEM imaging
Samples were mounted on aluminum stubs using a carbon adhesive film and were
subsequently coated with gold employing a Hummer® 6.2 sputtering system (Anatech
Ltd., Battlecreek, MI, USA) in a high-vacuum evaporator. The surface topography of each
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sample was analyzed by SEM at acceleration voltages of 1.0 kV –5.0 kV (JEOL JSM5600, JEOL, Inc., Peabody, MA, USA).

2.2.8 ATR-FTIR spectroscopy
FTIR spectra were collected using a Cary 660 bench top spectrometer (Agilent
Technologies, Santa Clara, CA, USA) with a MIRacle ATR sampling accessory (Pike
Technologies, Madison, WI, USA) equipped with a single-bounce diamond-coated ZnSe
internal reflection element. Samples were placed on the crystal surface and subjected to
a constant torque using the built-in pressure tower to achieve uniform solid–crystal
contact. Spectra were recorded at ambient temperature in the range of 4000−600 cm −1
using 32 scans at a resolution of 4 cm−1.

2.2.9 1H and 13C solution-phase NMR
Solution-phase NMR spectra were recorded on a Bruker BioSpin Ultrashield
spectrometer (400 MHz, Bruker, Rheinstetten, Germany) using dimethyl sulfoxide
(DMSO) as a solvent and tetramethylsilane as an internal reference to confirm the purity
of individual substances and the occurrence of salt formation.
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2.2.10 TGA
A PerkinElmer Pyris 1 TGA calorimeter was used to determine the thermal stability
of Indo, Tro, and their equimolar physical mixture and thus predict the thermal behavior
of this mixture in the hot melt extruder. Samples were placed in an open aluminum pan
and heated from 30 to 135 °C at a rate of 20 °C/min using ultra-purified nitrogen as the
purge gas at a flow rate of 25 mL/min. Pyris software was utilized for data
collection/analysis and for calculating percentage mass losses and/or onset
temperatures.

2.2.11 In vitro release study
The drug release properties of salts prepared via SE and HME were determined
using a United States Pharmacopeia (USP) basket-type dissolution apparatus I (Hanson
SR8-plus™, Hanson Research, Chatsworth, CA, USA) according to USP standards.
Specifically, 150 mL of pH 7.2 potassium phosphate monobasic buffer was mixed with
600 mL of deionized water to achieve a final pH of 7. All experiments were carried out in
triplicate at 37 ± 0.5 °C for 2 h using 750 mL of the dissolution medium. The basket
rotation speed was set to 100 rpm. Weighed salt samples with an Indo equivalent dose
of 50 mg were placed into size 2 gelatin capsules, and samples were withdrawn and
analyzed after 5, 15, 30, 45, 60, and 120 min. The amount of Indo released was
determined by HPLC (Waters Corp., Milford, MA, USA; detection at 254 nm) using
Empower software (version 2, Waters Corp.).
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2.2.12 Content uniformity
Accurately weighed amounts of HME-prepared salt equivalent to an Indo dose of
50 mg were randomly taken from the sample container, dissolved in suitable amounts of
the mobile phase, and sonicated. The sonicated dispersions were subjected to
appropriate dilutions, filtered, and analyzed by HPLC to determine the drug content.
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CHAPTER III

RESULTS AND DISCUSSIONS
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3.1 Salt formation by SE
The solvent evaporation method was employed to produce a high-quality salt that
was compared with the product obtained by HME. Specifically, 1:1, 2:1, 4:1, 1:2, and 1:4
(mol/mol) Indo:Tro mixtures were prepared by SE. The FTIR spectrum of the product
obtained at a 1:1 molar ratio was indicative of complete salt formation, whereas spectra
recorded at other ratios were not, i.e., a shoulder peak of amorphous Indo was observed
for 2:1 and 4:1 ratio’s, and no Tro N–H stretch shift was observed for 1:2 and 1:4 ratios.
DSC scans showed eutectic behavior at a 1:1 molar ratio, and the formed salt had a
distinct melting peak and was confirmed to be crystalline by PXRD. Based on the shifts
of the methylene group adjacent to the carboxylic group (3.7–3.48 ppm) observed by
solution-phase 1H NMR, salt formation was concluded to be complete at the 1:1 molar
ratio. The positional variability of the above shift was ascribed to the effects of proton
donation by the carboxyl group, which was thought to increase the electron density on
carboxyl oxygen and thus decrease its electron-withdrawing effect on the methylene
hydrogen [24]. TGA results indicated that no weight loss was observed for either Indo,
Tro, or their physical mixture.

3.2 Salt formation by continuous HME processing
Herein, we explored the use of HME as a continuous manufacturing process to
prepare an Indo-Tro salt by co-processing Indo-Tro blends with 1:1 and 2:1 Indo:Tro
molar ratios, and the morphology and dissolution profiles of the obtained samples were
compared. We hypothesized that the 1:1 sample should be more stable and exhibit a
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better/equivalent dissolution profile than the pure drug, the salt prepared by SE, and the
2:1 sample prepared by HME. Since tromethamine may adopt a cage-like structure
enabling numerous types of interactions, we wanted to determine if these interactions
allowed 2 equiv. of Indo to be stabilized by 1 equiv. of Tro. In view of the fact that HME
processing parameters (e.g., feed rate, configuration, and temperature profile)
significantly affect the quality of the obtained materials, these parameters were carefully
optimized. As a result, the highest crystallinity was achieved when extrusion was
performed at 135 °C at a feed rate of 5% and 150 rpm using a screw configuration
featuring two mixing blocks (Figure 1). The torque at 135 °C varied between 10% and
12%. Viscous dissipation was generated at the interfaces between the tacky melt, corotating twin screws, and the inner surface of the extruder barrel. Even though the
individual melting points of Indo and Tro significantly exceeded the working temperature,
the formation of a eutectic mixture decreased the melting point to much lower values.
When zone 5 of the extruder was opened, it was observed that the Indo-Tro mixture was
fully melted, and it was concluded that the salt crystallizes out after the interaction is
complete. In view of the conversion of the Indo-Tro blend to a tacky material during
extrusion, the time period between the feeding of the blend into the extruder and the exit
of the product (residence time) was determined as 8 min. Thus obtained product was
further used as an ideal formulation for all comparison studies and characterizations.
Samples produced by SE and HME exhibited identical melting points and similar
enthalpies, which indicated that essentially identical crystallinities were obtained in both
cases.
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Figure 1 Illustration of ideal screw configuration used in HME.

3.3 pH–solubility studies
The role of the pH–solubility relationship in aqueous media in determining the
feasibility of pharmaceutically acceptable salts of acidic and basic drugs has been
extensively studied [25]. The pH–solubility profile of an acidic drug may be expressed by
two independent curves, the intersection point of which is denoted as pHmax, i.e., the pH
of maximum solubility. The solubility curves above and below the pHmax may,
respectively, be determined by Eq. (1) and (2). At pH < pHmax, the solid phase in
equilibrium with the saturated solution is the free acid, whereas at pH > pHmax, it is the
salt, and both form co-exist at pH = pHmax. Thus, salt-to-acid interconversion (and vice
versa) may occur if the pH shifts away i.e. lower from pHmax [3]. Equations describing the
pH–solubility relationships of salt and free-acid forms of acidic compounds were first
established by Kramer and Flynn [22]:
ST acid (pH < pHmax) = [AH]s + [A–] = [AH]s ( 1 + Ka/[H3O+])
= [AH]s (1 + 10 pH – pKa)
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Eq. (1)

ST salt (pH > pHmax) = [A–]s + [AH] = [A–]s ( 1 + [H3O+]/ Ka)

Eq. (2)

= [A–]s (1 + 10 pKa – pH)
Where A- and AH are the deprotonated (salt) and free acid species of the drug,
respectively, ST is the total solubility at any particular pH, Ka is the acid dissociate
constant, and the subscript s denotes the equilibrium species in the solid state. Different
aqueous suspensions were used in multiple experiments to obtain solubility values
(Figure 2), and the solubility of Indo in water at 25 °C was determined as 0.9 µg/mL.
Figure 2 also shows that the complete pH−solubility profile was indeed represented by
two curves that intersected at pHmax ≈ 8.19. As mentioned above, the equilibrium species
present below pHmax is the free acid. When a new solid form precipitated out of the
solution, pH increased to values above 8. The solid phase in equilibrium with the solution
at such pH was shown to not be the free acid and was therefore concluded to be the
corresponding salt. The fact that a new solid form could be obtained by increasing pH to
values above pHmax by the addition of Tro illustrated the feasibility of forming a Tro salt of
Indo. The solubility of the Indo-Tro salt in the flat pH region of 8.15–8.3 was determined
as 19.34 mg/mL, gradually decreasing at pH > 8.3 because of the common ion effect.
The apparent Ksp of the salt was calculated as 1.63 × 10–3 M2 using the method of
Anderson and Conradi [26]. Figure 2 also revealed that after the pH of maximum salt
solubility was reached, the solubility exhibited a plateau and then decreased, in
agreement with Le Chatelier’s common ion effect. As the concentration of base increased
after full acid neutralization, the acid (Indo) precipitated out until the ion product became
equal to the solubility product [27].
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Figure 2 pH-Solubility profile of Indo (weak acid) titrated with Tro (weak base).

3.4 Characterization of the Indo-Tro interaction and the corresponding crystalline
salt by DSC
Solid-state reactions between acids and bases are likely to occur at elevated
temperatures [9], the pKa rule is generally accepted to predict salt formation. Since the
pKa difference between Indo and Tro equals 3.57, these species are likely to react and
form an organic salt at elevated temperature. Herein, the interaction between Indo and
Tro in physical mixtures at elevated temperature was initially studied by DSC analysis
with a heat−cool−heat temperature cycle. Figure 3 shows that pure Indo melted at 162
°C, whereas pure Tro melted at 143 °C (metastable polymorph) and 171 °C (stable
polymorph). Notably, Indo-Tro binary mixtures demonstrated interesting thermal
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behaviors, e.g., “eutectic-like” endothermic events (136 °C) at temperatures below the
individual melting points of both Indo and Tro were observed in the binary mixture, which
was attributed to the suppression of Indo melting in the presence of Tro. The salt obtained
by HME had a melting point of 142 °C, which was identical to that of the crystalline salt
prepared by SE. As shown in Figure 3, the melting peak of newly formed crystals was
almost superimposed on the first melting peak of the metastable polymorph of
tromethamine. When tromethamine was cooled and reheated, its melting point was
determined as 148 °C, which indicated that the salt peak did not correspond to that of the
recrystallized metastable tromethamine polymorph. Moreover, no Tg or additional melting
peaks were observed, and we therefore ascribed the new peak to the melting of the newly
formed crystalline salt with a low lattice energy. Generally, performing TGA analysis prior
to HME is of critical importance, since the high temperature experienced by the drug
and excipients during extrusion may result in the occurrence of degradation, thermally
induced chemical reactions, or both [28]. Herein, the obtained TGA results revealed that
Indo, Tro, and their equimolar physical mixture were chemically stable in the temperature
range of HME processing (data not shown).
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Figure 3 DSC scans of (A) Indo, (B) Tro, (C) 1:1 Indo-Tro physical mixture, (D) 1:1 IndoTro crystalline salt prepared by SE and (E) 1:1 Indo-Tro crystalline salt prepared by HME.

3.5 Characterization of the Indo-Tro interaction by HSPLM
HSPLM imaging was utilized to further understand the thermal events observed in
DSC analysis. Figure 4 shows a correlation between the DSC thermogram and the
HSPLM photomicrographs observed for the equimolar physical mixture of Indo and Tro
heated at a rate of 20 °C/min. Indo and Tro were easily distinguishable based on their
irregular crystal shapes, as confirmed by the results of SEM imaging. When the above
species were tested individually, no thermal event was observed by HSPLM until the
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respective melting temperatures (143 °C (metastable polymorph) and 171 °C (stable
polymorph) for Tro and 162 °C for Indo) were reached. Conversely, Tro began to melt
around 110 °C in the Indo−Tro physical mixture, whereas Indo crystals gradually
dissolved in molten Tro, and complete mixing was achieved before any of the individual
melting points was reached. Thus, the results of DSC and HSPLM analyses indicated
that Indo and Tro reacted to form a salt upon thermal treatment. Crystallization of a
molecular complex following the solubilization of one component into the melt of the other
one has been achieved by other solubility enhancement techniques for substrates such
as co-amorphous materials and co-crystals.
The real-time monitoring of in situ intermediate formation during mechanochemical
milling is challenging [29]. Herein, the rate of melting was much faster for the lowermelting-point component (i.e., tromethamine metastable polymorph), and this melting
therefore produced a large amount of “solvent” for the higher-melting-point component,
which first dissolved in the melt and then transformed into a more stable crystalline state.
Similar results have been reported for the thermally induced formation of carbamazepine–
nicotinamide co-crystals [30]. In conclusion, the results of HSPLM imaging indicated that
Indo and Tro formed an Indo-Tro salt in situ at elevated temperature.
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Figure 4 Hot stage polarized light microscopy of 1:1 Indo-Tro physical mixture.

3.6 Characterization of the crystalline salt by PXRD
The PXRD pattern of the salt obtained by HME was compared to that of the salt
obtained by solution-phase crystallization and those of individual components and their
physical mixture. The PXRD pattern of Indo resembled that reported for the Ɣ-form, in
agreement with the interpretation of DSC results [31], featuring intense reflections in the
2θ = 10−35° range that were indicative of a complex crystal structure (Figure 5), namely
at 2θ = 10°, 11°, 19°, 22°, 29°, and 34°. For Tro, intense signals compliant with its intricate
crystal lattice arrangement were observed at 2θ = 14– 27° (Figure 5), namely at 14°, 18°,
20°, 22.5°, 25°, and 27°. Salts produced by both SE and HME exhibited a distinct peak
with significant intensity at 2θ = 12.55°. Moreover, the salt produced by the latter method
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was shown to be crystalline by DSC analysis. The impact of process parameters was
distinctly revealed by PXRD analysis, i.e., when non-optimal conditions were applied, a
single dominant amorphous halo at 2θ = 21° was observed in place of the above
crystalline phase peak (data not shown), in agreement with the results of DSC analysis.
The diffractogram of the Indo-Tro physical mixture showed reflections belonging to
individual Indo and Tro (Figure 5).

Figure 5 XRPD scans of (A) Indo, (B) Tro, (C) 1:1 Indo-Tro crystalline salt prepared by
SE and (D) 1:1 Indo-Tro crystalline salt prepared by HME.

3.7 Characterization of surface morphology by SEM
SEM was used as a technique providing direct visual evidence and capable of
confirming crystalline salt formation to examine the surface morphology of the drug, co-
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former, and salts produced by SE and HME. Indo was shown to exist as irregularly shaped
plate-like crystals, whereas Tro formed rough and thick plate-like irregular crystals. Repka
et al. claimed that particles of crystalline compounds should have a rough surface when
imaged by SEM [32]. In agreement with this statement, the image obtained for the highly
crystalline salt showed extremely rough particle surfaces, whereas the amorphous
product contained particles with smooth surfaces. Moreover, the crystalline salt obtained
by SE featured a surface morphology similar to that of the salt produced by HME (Figure
6). Thus, these results suggested that the formation of a crystalline salt in this case was
highly probable, and the good content uniformity of HME systems confirmed that the
degrees of mixing and salt formation in the hot melt extruder were acceptably high.
Therefore, the results of SEM imaging were consistent with those of DSC and PXRD
analyses.

Figure 6 Scanning electron microscopy images of (A) Indo, (B) Tro, (C) 1:1 Indo-Tro
crystalline salt prepared by SE, (D) 1:1 Indo-Tro crystalline salt prepared by HME and (E)
1:1 Indo-Tro amorphous product prepared by HME.
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3.8 Characterization of the crystalline salt by FTIR spectroscopy
Salts can be categorized into those exhibiting ionic interaction (as result of proton
transfer) or non-ionic interaction with varying degrees of proton sharing via H-bonding
[33], with complete proton transfer between acidic and basic components occurring for
ΔpKa > 3.0 [21]. Since Indo and Tro have pKas of 4.5 and 8.07, respectively, we
hypothesized that ionic interaction with full proton transfer was possible. However, proton
transfer is also affected by molecular packing and processing conditions. Herein, FTIR
spectroscopy and NMR were used to determine the interaction between Indo and Tro,
showing the occurrence of full proton transfer. The former technique is often used to
detect salt formation based on the ionization state of acidic and basic components. In this
work, FTIR analysis offered crucial information on salt formation, since the variation in
vibrational frequencies was correlated with changes in hydrogen bonding caused by the
formation of multicomponent crystals. Figure 7 shows the wavenumbers of important Indo
and Tro groups involved in salt formation. Salt was formed via proton transfer from the
carboxylic acid group of Indo to the primary amine of Tro, which was the most basic site.
The antisymmetric C=O stretch of the ionized carboxyl group is typically observed
between 1540 and 1650 cm−1 [34]. The band reflecting N−H stretching shifted from 3327
to 3370 cm−1, which indicated that the primary amine group of Tro was involved in salt
formation. Moreover, a new peak (Figure 8) at 1570 cm−1 was observed for 1:1 salts
obtained by SE and HME. To reveal the reason why the 1:1 molar ratio worked best, we
recorded FTIR spectra of SE–processed mixtures with Indo:Tro ratios of 1:1, 2:1, 4:1, 1:2,
and 1:4 (Figure 9). In the case of the 2:1 ratio, a shoulder around 1750 cm −1 was
observed, which indicated the presence of amorphous Indo, and the observation of the
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salt-specific peak implied that 1 equiv. of Indo reacted with 1 equiv. of Tro to form a salt.
In the case of the 4:1 ratio, the observation of the COOH carbonyl stretch revealed the
presence of excess Indo. Finally, the NH bending peak at 1584 cm−1 detected in 1:2 and
1:4 mixtures completely overpowered Indo peaks, indicating the presence of excess Tro.

Figure 7 FTIR ranges of (A) Indo and (B) Tro.
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Figure 8 FTIR spectra of (A) Indo, (B) Tro, (C) 1:1 Indo-Tro crystalline salt prepared by
SE, (D) 1:1 Indo-Tro crystalline salt prepared by HME.

Figure 9 FTIR spectra of different molar ratios of Indo-Tro prepared by SE (A) 1:1, (B)
2:1, (C) 4:1, (D) 1:2 and (E) 1:4.
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3.9 Characterization of the crystalline salt via solution-phase NMR
Although one can deduce which positions are protonated based on chemical
reasoning and pKa value computations, FTIR does not directly indicate which carbon
atoms are involved in deprotonation. Conversely, the sensitivity of NMR to subtle changes
in the electronic environment of the nuclei of interest make it an excellent technique for
investigating deprotonation sites [35]. Herein, the results of 1H solution-phase NMR
confirmed the occurrence of salt formation, since the protons of the methylene group
adjacent to the carboxyl carbon showed an upfield shift from 3.7 ppm to 3.4 ppm (Figure
10). Moreover, whereas the spectrum of pure Indo featured an acidic proton signal at 12.4
ppm, no such peak was observed for crystalline salts prepared by SE and HME, which
indicated that this proton was transferred to the base (Figure 11). 13C solution-phase NMR
spectra of Indo and 1:1 salt prepared by HME are shown in Figure 12. The spectra of
Indo and Tro were in good agreement with those reported previously. Notably,
deprotonation at the carboxylic carbon induced a downfield shift from 172.1 to 174.4 ppm,
which indicated that deprotonation occurred at a specific carboxylic carbon nucleus [36].
Additionally, DEPT 135 experiments were conducted to observe the effects of protonation
on the methylene group adjacent to the primary amine group of the base and on the
methylene group adjacent to the carboxylic group of the acid. As a result, the methylene
signal of the free base shifted upfield to 60.2 ppm from 63.2 ppm, and the signal of the
methylene group of the acid shifted downfield to 32.8 ppm (Figure 13), which was
indicative of salt formation and agreed with the results of the protonation/deprotonation
study of Schneider et al. [24]. To eliminate the possibility of ionization in DMSO, the
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physical mixture of Indo and Tro was also studied, and the shift observed for the physical
mixture was shown to be very small compared to that observed for the salt.

Figure 10 1H NMR of (A) Indo, (B) Tro, (C) 1:1 Indo-Tro physical mixture, (D) 1:1 IndoTro crystalline salt prepared with SE and (E) 1:1 Indo-Tro crystalline salt prepared by
HME.
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Figure 11 1H NMR of (A) Indo, (B) 1:1 Indo-Tro crystalline salt prepared with SE and (C)
1:1 Indo-Tro crystalline salt prepared by HME.
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Figure 12 13C NMR of (A) Indo and (B) 1:1 Indo-Tro crystalline salt prepared by HME.
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Figure 13 DEPT 135 NMR of (A) Indo (B) Tro and (C) 1:1 Indo-Tro crystalline salt
prepared with HME.

3.10 In vitro release/content uniformity
Salt formation is known to influence several physicochemical properties of the
parent compound including dissolution rate, solubility, stability, and hygroscopicity. In
turn, these properties affect drug availability and formulation characteristics. The
dissolution rate of a pharmaceutical agent is of major importance to the formulator, since
in many cases, particularly for poorly soluble drugs, it best reflects bioavailability [37]. As
a rule, pharmaceutical salts exhibit higher dissolution rates than the corresponding
conjugate acids or bases at identical pH, even though the equilibrium solubilities may be
equal [3]. In this study, solubility enhancement via HME-induced crystalline salt formation
was evaluated by in vitro dissolution testing, with the results presented in Figures 14 and
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15. Specifically, the used dissolution medium (final pH = 7) described in the USP
monograph on Indo, and the equilibrium solubility of Indo in this medium at 37 °C was
determined as 15.1 μg/mL. Dissolution testing was performed using salt samples
prepared by HME and SE so that the nominal concentration of Indo equaled 66.6 μg/mL.
The dissolution profile of pure Indo was markedly different from those of the 1:1 mixture
and crystalline salts (Figure 14). Notably, 100% of the drug was released within 5 min
from salts prepared by either method, and the solubility of Indo in the salt form was shown
to exceed that of the free acid form by a factor of 4.6. Conversely, the 1:1 physical mixture
of Indo and Tro showed a drug release of ~80% over 2 h. Indo has pH dependent
solubility; Tro affects the pH environment of the dissolution media thus giving better profile
than the drug. The drug release profile of the crystalline salt was also compared to those
of the 2:1 mixture and the amorphous tacky mass of 1:1 composition (Figure 15). As a
result, a release of only 70% over 2 h was observed in the former case, which indicated
that some salt might have formed, while the remaining Indo possibly underwent slow
recrystallization upon contact with the medium. The 1:1 amorphous tacky mass also
exhibited poor dissolution performance compared to the 1:1 crystalline salt, which was
ascribed to the occurrence of high-temperature degradation reactions in the former case,
i.e., those leading to aldehyde formation instead of ionic interaction. This aldehyde
formation was detected by NMR, and the corresponding HPLC profiles featured a new
separate peak not attributed to Indo. Based on the obtained data, HME resulted in the
uniform mixing of the drug with the co-former to achieve content uniformity, which is one
of the key factors to take into consideration for formulation development. The drug content
of extruded formulations was determined as 98.8 ± 1%, and the lower standard deviation
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obtained for the extruded salt indicated that the optimized screw configuration provided
sufficient mixing and resulted in a homogenous interaction between Indo and Tro.

Figure 14 Dissolution profiles of (A) Indo, (B) 1:1 Indo-Tro physical mixture (C) 1:1 IndoTro crystalline salt prepared by SE and (D) 1:1 Indo-Tro crystalline salt prepared with
HME in 750 mL of pH 7 media using USP apparatus I at 100 rpm (n = 3).
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Figure 15 Dissolution profiles of (A) Indo, (B) 2:1 Indo-Tro prepared with HME, (C) 1:1
Indo-Tro tacky mass prepared with HME at 145°C and (D) 1:1 Indo-Tro crystalline salt
prepared with HME in 750 mL of pH 7 media using USP apparatus I at 100 rpm (n = 3).
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CHAPTER IV

CONCLUSION
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This research focused on increasing the solubility of a poorly water-soluble drug, Indo, by
converting it into a salt form using Tro as the co-former. In view of the fact that techniques
commonly used for salt formation require the use of organic solvents and are batch
processes, we herein employed HME as an alternative continuous and solvent-free
method. The obtained pH–solubility profiles suggested that salt formation between Indo
and Tro is feasible at a 1:1 molar ratio, and the corresponding mixture was shown to
exhibit eutectic melting by DSC and HSPLM. The crystalline nature of the prepared salt
was confirmed by PXRD and SEM, and solution-phase NMR and FTIR spectroscopy
suggested the occurrence of a strong ionic interaction accompanied by proton transfer
from Indo to Tro. Salt formation increased the dissolution rate of Indo in aqueous medium,
achieving a 100% drug release in less than 5 min. Crystalline salts prepared by SE and
HME showed similar physicochemical characteristics, and the latter method was
therefore concluded to be a promising solvent-free alternative for the preparation of
crystalline salts, contributing to the elimination of batch processing while achieving
comparable quality.
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